Matches in Nanopublications for { <http://www.nextprot.org/nanopubs#NX_O95863-1_MUTAGEN_107_107.RAWTDDn4yKdKZoYF9O_I1Y3-35XoApUHW6SfGM6je6h08._4> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NX_O95863-1_MUTAGEN_107_107.RAWTDDn4yKdKZoYF9O_I1Y3-35XoApUHW6SfGM6je6h08._4 type RangedSequencePosition NX_O95863-1_MUTAGEN_107_107.RAWTDDn4yKdKZoYF9O_I1Y3-35XoApUHW6SfGM6je6h08.assertion.
- NX_O95863-1_MUTAGEN_107_107.RAWTDDn4yKdKZoYF9O_I1Y3-35XoApUHW6SfGM6je6h08._4 type SO_0001148 NX_O95863-1_MUTAGEN_107_107.RAWTDDn4yKdKZoYF9O_I1Y3-35XoApUHW6SfGM6je6h08.assertion.
- NX_O95863-1_MUTAGEN_107_107.RAWTDDn4yKdKZoYF9O_I1Y3-35XoApUHW6SfGM6je6h08._4 comment "Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-111; A-115 and A-119. Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-96; A-100; A-111; A-115 and A-119. Increases protein stability, does not affect repressor activity on E-cadherin promoter, preferentially localizes to the nucleus, induces a more aggressive tissue invasion program and impairs phosphorylation by GSK3B, binding to BTRC and ubiquitination; when associated with A-104. Impairs phosphorylation in the serine-rich region; when associated with A-92 and A-104. Abolishes phosphorylation at S-96." NX_O95863-1_MUTAGEN_107_107.RAWTDDn4yKdKZoYF9O_I1Y3-35XoApUHW6SfGM6je6h08.assertion.
- NX_O95863-1_MUTAGEN_107_107.RAWTDDn4yKdKZoYF9O_I1Y3-35XoApUHW6SfGM6je6h08._4 SIO_000053 NX_O95863-1_MUTAGEN_107_107.RAWTDDn4yKdKZoYF9O_I1Y3-35XoApUHW6SfGM6je6h08._5 NX_O95863-1_MUTAGEN_107_107.RAWTDDn4yKdKZoYF9O_I1Y3-35XoApUHW6SfGM6je6h08.assertion.
- NX_O95863-1_MUTAGEN_107_107.RAWTDDn4yKdKZoYF9O_I1Y3-35XoApUHW6SfGM6je6h08._4 SIO_000053 NX_O95863-1_MUTAGEN_107_107.RAWTDDn4yKdKZoYF9O_I1Y3-35XoApUHW6SfGM6je6h08._6 NX_O95863-1_MUTAGEN_107_107.RAWTDDn4yKdKZoYF9O_I1Y3-35XoApUHW6SfGM6je6h08.assertion.